| European Federation of Internal Medicine

European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News

Type: News Feed

Report - HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment

Submitted by Anonymous (not verified) on 5 June 2026 - 15:12

Report - HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment

Read more about Report - HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment

PSUSA/00000491/202506

Submitted by Anonymous (not verified) on 5 June 2026 - 15:00

PSUSA/00000491/202506

Read more about PSUSA/00000491/202506

Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Date of authorisation: 06/02/2009, Revision: 27, Status: Authorised

Submitted by Anonymous (not verified) on 5 June 2026 - 14:55

Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Date of authorisation: 06/02/2009, Revision: 27, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Date of authorisation: 06/02/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 5 June 2026 - 14:41

Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 5, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 5, Status: Authorised

Member states contact points for translations review

Submitted by Anonymous (not verified) on 5 June 2026 - 14:26

Member states contact points for translations review

Read more about Member states contact points for translations review

Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 25, Status: Authorised

Submitted by Anonymous (not verified) on 5 June 2026 - 14:04

Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 25, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 27, Status: Authorised

Submitted by Anonymous (not verified) on 5 June 2026 - 14:03

Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 27, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 27, Status: Authorised

Standard operating procedure for the preparation of ESUAvet annual reports

Submitted by Anonymous (not verified) on 5 June 2026 - 13:56

Standard operating procedure for the preparation of ESUAvet annual reports

Read more about Standard operating procedure for the preparation of ESUAvet annual reports

Human medicines European public assessment report (EPAR): Dasselta, desloratadine, Date of authorisation: 28/11/2011, Revision: 14, Status: Authorised

Submitted by Anonymous (not verified) on 5 June 2026 - 13:42

Human medicines European public assessment report (EPAR): Dasselta, desloratadine, Date of authorisation: 28/11/2011, Revision: 14, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Dasselta, desloratadine, Date of authorisation: 28/11/2011, Revision: 14, Status: Authorised

European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Report - HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment

PSUSA/00000491/202506

Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Date of authorisation: 06/02/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 5, Status: Authorised

Member states contact points for translations review

Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 27, Status: Authorised

Standard operating procedure for the preparation of ESUAvet annual reports

Human medicines European public assessment report (EPAR): Dasselta, desloratadine, Date of authorisation: 28/11/2011, Revision: 14, Status: Authorised

Newsletters

Latest Newsletters

You are here

Newsletters

Latest Newsletters